# Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia

> **NCT00804297** · PHASE3 · COMPLETED · sponsor: **Albert Einstein Healthcare Network** · enrollment: 40 (—)

## Conditions studied

- Hypoglycemia
- Diabetes Mellitus

## Interventions

- **DRUG:** Octreotide (drug)

## Key facts

- **NCT ID:** NCT00804297
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804297, "Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00804297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*